Medical News

RSS

Researchers uncover vulnerabilities in elusive HIV reservoir clones

A new study has overcome a long-standing challenge-how to isolate and study elusive HIV-infected cells called authentic reservoir clones (ARCs) that evade the immune system, making the disease difficult to cure.

24 Feb 2026

Study sheds light on behavior of yeast cells in the gut

A new study sheds light on the behavior of yeast cells in the gut, paving the way for new lines of yeast that more efficiently produce therapeutic drugs tailored to address specific diseases.

24 Feb 2026

Study reveals knowledge gaps about menstrual health in elite women’s football

Elite European women’s football players and staff show substantial knowledge gaps about menstrual health and hormonal contraception despite widespread openness to discussion. The study highlights the need for structured education to support informed health decisions while clarifying that perceived performance effects are not consistently supported by scientific evidence.

24 Feb 2026

Hip exoskeleton reduces walking effort in stroke survivors

A leading cause of disability in the United States is hemiparesis, a condition where impaired motor control, muscle weakness, and spasticity affect one side of the body.

24 Feb 2026

ARPA-H-funded PROSPR program focuses on the biological hallmarks of aging

Columbia University Mailman School of Public Health has received an award as part of the PROactive Solutions for Prolonging Resilience (PROSPR) program within the Advanced Research Projects Agency for Health (ARPA-H) to accelerate research on the biological hallmarks of aging.

24 Feb 2026

New global guidelines improve reporting of pediatric randomized controlled trials

Researchers at The Hospital for Sick Children (SickKids), working with international collaborators and youth and family caregivers, have developed a child- and youth-centred global standard for reporting paediatric randomized controlled trials (RCTs) protocols and final reports.

24 Feb 2026

Untreated sleep apnea may cost the UK and US billions annually

Untreated obstructive sleep apnea may be costing the UK and US economies billions of pounds/dollars in lost productivity every year, with a considerable proportion of working age adults experiencing symptoms indicative of the breathing disorder, suggests an analysis published online in the journal Thorax.

24 Feb 2026

Parental obesity before conception raises offspring fatty liver risk

Pre-pregnancy parental overweight and obesity is linked to the next generation's heightened risk of developing fatty liver disease, a potential precursor to cirrhosis and liver failure, suggests research published online in the journal Gut.

24 Feb 2026

Teen cannabis use trends mirror established alcohol consumption patterns

A new study published in the journal Addiction shows that cannabis use among Swedish adolescents appears to follow the same population-level pattern previously observed for alcohol.

24 Feb 2026

Longevity treatments extend life but affect variation in age-at-death

A key goal in aging research is not just to extend life, but to ensure more people live longer and healthier lives with less variation in age-at-death; a concept known as "squaring the survival curve."

24 Feb 2026

Chimpanzee urine confirms widespread alcohol consumption in the wild

Aleksey Maro knows far more than he cares to know about the urination habits of chimpanzees. But if you want to measure the alcohol intake of chimps in a Ugandan rain forest, where a breathalyzer is impractical, collecting urine for analysis is your only choice.

24 Feb 2026

Infographics engage unmotivated young adults in healthy eating

Young adults who are not motivated to eat healthily can still be engaged with the right type of communication, according to new research from the European Food Information Council (EUFIC).

24 Feb 2026

US measles and pertussis outbreaks expose policy failures, not just vaccine hesitancy

A recent commentary argues that US measles and pertussis outbreaks are not simply the result of vaccine hesitancy but reflect weakened immunization policies, permissive exemptions, and underfunded public health systems. The authors contend that policy environments determine whether pockets of low coverage escalate into large-scale, preventable outbreaks.

24 Feb 2026

Combined GLP-1 and GLP-2 treatment appears safe but does not beat placebo for obesity

In a 12-week randomized phase IIa trial in adults with obesity, the dual GLP-1/GLP-2 receptor agonist dapiglutide was well tolerated but did not achieve statistically significant weight loss compared with placebo at 4 mg or 6 mg doses. Although the higher dose showed modest within-group weight reduction and improved HbA1c, unexpectedly substantial placebo-associated weight loss limited the observed treatment effect.

24 Feb 2026

New antimicrobial strategies show how science is tackling rising drug resistance

This narrative review in the British Journal of Biomedical Science examines emerging and recently approved therapeutic strategies to combat antimicrobial resistance, spanning new antibiotics, microbiome interventions, natural products, predatory bacteria, vaccines, and advanced technologies. It highlights both promising innovations and the urgent need for sustained global investment as many approaches remain in early development.

24 Feb 2026